Monogram Technologies' Executives Invest $1 Million in Company Stock

Monogram Technologies Inc., an AI-driven robotics company, has announced that senior management and related parties have purchased $1 million worth of MGRM common stock on the open market. This move, including a purchase by Chief Financial Officer Noel Knape, reflects the team's confidence in Monogram's strategy to enhance shareholder value. CEO Ben Sexson highlighted this confidence as part of their strategy following recent funding.

The company is focusing on achieving several upcoming milestones. These include a meeting with the FDA by December 2024, seeking regulatory clearance for trials in India with Shalby Hospitals, obtaining FDA clearance for the mBôs™ TKA System, and expanding international relationships. Monogram will showcase its innovations at Arab Health in January 2025.